These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29575763)

  • 1. DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34
    Maupetit-Mehouas S; Court F; Bourgne C; Guerci-Bresler A; Cony-Makhoul P; Johnson H; Etienne G; Rousselot P; Guyotat D; Janel A; Hermet E; Saugues S; Berger J; Arnaud P; Berger MG
    Mol Oncol; 2018 Jun; 12(6):814-829. PubMed ID: 29575763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cells.
    Porro A; Iraci N; Soverini S; Diolaiti D; Gherardi S; Terragna C; Durante S; Valli E; Kalebic T; Bernardoni R; Perrod C; Haber M; Norris MD; Baccarani M; Martinelli G; Perini G
    Mol Cancer Res; 2011 Aug; 9(8):1054-66. PubMed ID: 21693596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors.
    Sun B; Jiang G; Zaydan MA; La Russa VF; Safah H; Ehrlich M
    Cancer Res; 2001 Sep; 61(18):6931-7. PubMed ID: 11559572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemia.
    Rogers SL; Zhao Y; Jiang X; Eaves CJ; Mager DL; Rouhi A
    Mol Cancer; 2010 Feb; 9():41. PubMed ID: 20175919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse relationship between myeloid maturation and leukotriene C4 synthase expression in normal and leukemic myelopoiesis-consistent overexpression of the enzyme in myeloid cells from patients with chronic myeloid leukemia.
    Tornhamre S; Stenke L; Granzelius A; Sjölinder M; Näsman-Glaser B; Roos C; Widell S; Lindgren JA
    Exp Hematol; 2003 Feb; 31(2):122-30. PubMed ID: 12591277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia.
    Zhou JD; Lin J; Zhang TJ; Ma JC; Li XX; Wen XM; Guo H; Xu ZJ; Deng ZQ; Zhang W; Qian J
    J Cell Physiol; 2018 Mar; 233(3):2444-2450. PubMed ID: 28776669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase.
    Diaz-Blanco E; Bruns I; Neumann F; Fischer JC; Graef T; Rosskopf M; Brors B; Pechtel S; Bork S; Koch A; Baer A; Rohr UP; Kobbe G; von Haeseler A; Gattermann N; Haas R; Kronenwett R
    Leukemia; 2007 Mar; 21(3):494-504. PubMed ID: 17252012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls.
    de Cássia Viu Carrara R; Fontes AM; Abraham KJ; Orellana MD; Haddad SK; Palma PVB; Panepucci RA; Zago MA; Covas DT
    Clin Transl Oncol; 2018 Apr; 20(4):542-549. PubMed ID: 28905209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCR-ABL1 tyrosine kinase sustained MECOM expression in chronic myeloid leukaemia.
    Roy S; Jørgensen HG; Roy P; Abed El Baky M; Melo JV; Strathdee G; Holyoake TL; Bartholomew C
    Br J Haematol; 2012 May; 157(4):446-56. PubMed ID: 22372463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34+CD7+ leukemic progenitor cells may be involved in maintenance and clonal evolution of chronic myeloid leukemia.
    Kosugi N; Ebihara Y; Nakahata T; Saisho H; Asano S; Tojo A
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):505-11. PubMed ID: 15701834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation status of CEBPA gene promoter in chronic myeloid leukemia.
    Annamaneni S; Kagita S; Gorre M; Digumarti RR; Satti V; Battini MR
    Hematology; 2014 Jan; 19(1):42-4. PubMed ID: 23541085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methylation status of JunB and CDH13 gene promoter in CD34(+)CD38(-) chronic myelogenous leukemia cells].
    Wang XJ; Li J; Fu BJ; Guo LL; Zhang JH; Huang SA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1405-8. PubMed ID: 20030915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors.
    Pietarinen PO; Eide CA; Ayuda-Durán P; Potdar S; Kuusanmäki H; Andersson EI; Mpindi JP; Pemovska T; Kontro M; Heckman CA; Kallioniemi O; Wennerberg K; Hjorth-Hansen H; Druker BJ; Enserink JM; Tyner JW; Mustjoki S; Porkka K
    Oncotarget; 2017 Apr; 8(14):22606-22615. PubMed ID: 28186983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Cervantes F; Sanchez J; Garate L; Barrios M; Castillejo JA; Navarro G; Colomer D; Prosper F; Heiniger A; Torres A
    Oncogene; 2005 Nov; 24(48):7213-23. PubMed ID: 16170379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy.
    Ferri C; Bianchini M; Bengió R; Larripa I
    Blood Cells Mol Dis; 2014; 52(2-3):121-5. PubMed ID: 24091144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
    Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia.
    Qian J; Wang YL; Lin J; Yao DM; Xu WR; Wu CY
    Eur J Haematol; 2009 Feb; 82(2):119-23. PubMed ID: 19018866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia.
    Heller G; Topakian T; Altenberger C; Cerny-Reiterer S; Herndlhofer S; Ziegler B; Datlinger P; Byrgazov K; Bock C; Mannhalter C; Hörmann G; Sperr WR; Lion T; Zielinski CC; Valent P; Zöchbauer-Müller S
    Leukemia; 2016 Sep; 30(9):1861-8. PubMed ID: 27211271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methylation status of id4 gene promoter in patients with chronic myeloid leukemia].
    Wang XR; Kang HY; Cen J; Li YH; Wang LL; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1402-4. PubMed ID: 21176338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence.
    Bruns I; Czibere A; Fischer JC; Roels F; Cadeddu RP; Buest S; Bruennert D; Huenerlituerkoglu AN; Stoecklein NH; Singh R; Zerbini LF; Jäger M; Kobbe G; Gattermann N; Kronenwett R; Brors B; Haas R
    Leukemia; 2009 May; 23(5):892-9. PubMed ID: 19158832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.